특수 PACS 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the specialty PACS market size was valued at USD 2.77 billion in 2025 and estimated to grow from USD 2.95 billion in 2026 to reach USD 4.07 billion by 2031, at a CAGR of 6.64% during the forecast period (2026-2031).

This report is Segmented by Specialty (Radiology PACS, Cardiology PACS, Pathology PACS, Ophthalmology PACS, and More), by Component (Software, Services, Hardware), by Deployment Model (On-Premise PACS, Web/Cloud-based Specialty PACS, Hybrid PACS), by End User (Hospitals, Diagnostic Imaging Centers, and More), by Geography (North America, Europe, Asia-Pacific, and More).

Global Specialty PACS Market Trends and Insights

Growing Use of Imaging Devices

Advanced photon-counting CT and digital SPECT entered commercial deployment in 2025, intensifying imaging throughput and expanding modality diversity. Point-of-care ultrasound adoption remains high in post-pandemic environments, compelling providers to select Specialty PACS market platforms that manage data from mobile devices as effortlessly as radiology suites. Double-digit reimbursement growth for coronary CT angiography further increases scan volumes, magnifying the need for vendor-neutral archives. These dynamics elevate AI-driven workflow tools that automate triage and reporting across modalities, underscoring why health systems are modernizing Specialty PACS market infrastructure rather than extending legacy contracts.

Increasing Burden of Chronic Diseases

Global diabetes prevalence and aging populations are reshaping ophthalmology and cardiology imaging workflows. AI models now deliver 100% sensitivity in diabetic retinopathy screening, prompting eye clinics to embed longitudinal comparison features within Specialty PACS market environments. Echocardiography studies also require integrated cardiovascular information systems for precise trend analysis, while oncology practices demand cross-specialty image aggregation to align with precision medicine protocols.

Data Security & Privacy Concerns

Ransomware groups such as Rhysida are targeting imaging archives, with one Pennsylvania breach costing USD 65 million in settlements and drawing attention to PACS vulnerabilities. Upcoming mandatory U.S. cybersecurity requirements will likely drive urgent Specialty PACS market upgrades, yet lengthy security assessments delay go-lives. Vendors now tout zero-trust architectures and end-to-end encryption, but steep learning curves can slow clinician adoption.

Other drivers and restraints analyzed in the detailed report include:

1. Enterprise-wide Imaging Adoption
2. AI-ready Architecture Demand
3. High Capex & Migration Costs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Radiology accounted for 45.20% of Specialty PACS market share in 2025, a testament to its status as the imaging backbone for acute and outpatient care. Adoption remains steady as enterprise imaging budgets prioritize large-volume radiology workflows. In contrast, Ophthalmology posted an 8.55% CAGR outlook to 2031, spurred by AI-enabled retinal screening programs that flag diabetic macular edema with 97% accuracy. The Specialty PACS market size for ophthalmology is projected to widen as public health agencies sponsor mass screening, demanding longitudinal comparison features absent from older departmental systems. Cardiology PACS growth continues via tight integration with echocardiography reporting suites, whereas digital pathology gains momentum through telepathology mandates in Europe.

Second-tier specialties such as neurology and women's health are integrating AI modules for stroke detection and breast density assessment, catalyzing adoption beyond tertiary centers. Orthopedic and dermatology segments benefit from sports medicine demand and AI lesion analysis but contend with interoperability gaps that lengthen procurement cycles. The Specialty PACS market ultimately favors vendors offering configurable workflows that honor specialty nuances while sharing a common enterprise backbone.

Software retained 58.70% share of the Specialty PACS market size in 2025, reflecting entrenched license footprints across hospital networks. However, services-hosting, migration, cybersecurity, and AI model management-are forecast for an 8.18% CAGR, outpacing software due to hospitals' shift toward outcome-based contracts. Increasingly, CIOs choose managed cloud PACS to offset talent shortages and rapidly deploy new features. The Specialty PACS market now rewards vendors that bundle 24/7 monitoring and continuous performance tuning rather than relying on periodic version upgrades.

Hardware revenues plateau as data center consolidation and virtualization reduce workstation refresh volumes. Nevertheless, high-resolution diagnostic displays and local caching appliances remain essential for latency-sensitive use cases. Subscription models linked to imaging volume provide budget predictability, aligning vendor incentives with provider operational efficiency goals.

Complete Report Scope:

• By Specialty
  • Radiology PACS
  • Cardiology PACS
  • Pathology PACS
  • Ophthalmology PACS
  • Orthopedic PACS
  • Oncology PACS
  • Dermatology PACS
  • Neurology PACS
  • Women's Health PACS
  • Other Specialty PACS
• By Component
  • Software
  • Services
  • Hardware
• By Deployment Model
  • On-premise PACS
  • Web/Cloud-based Specialty PACS
  • Hybrid PACS
• By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers & Clinics
  • Research & Academic Institutes
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 43.85% of Specialty PACS market share in 2025, supported by mature reimbursement schemes and leading-edge cloud strategies. CMS telehealth expansions and an FDA AI framework foster a permissive environment for rapid product iteration. Canon Medical's USD 34 million Cleveland facility underscores the region's pull for R&D investment. Heightened cybersecurity mandates, however, raise compliance expenses and lengthen implementation testing cycles.

Asia-Pacific is forecast to post a 9.15% CAGR, the fastest among all regions. Singapore earmarked USD 200 million for AI innovation, while South Korea's 1.2 trillion won (USD 830 million) smart-hospital program accelerates Specialty PACS market penetration.Cloud PACS adoption mitigates IT staffing gaps, and private equity funds target regional imaging chains for roll-up strategies. The AI in medtech segment is projected to reach USD 250 million by 2028, further bolstering imaging IT demand.

Europe enjoys steady uptake driven by GDPR-aligned cloud services and cross-border digital-health projects. Philips expanded enterprise imaging on AWS to service EU providers, integrating automated AI reporting while safeguarding data privacy. Nevertheless, divergent national procurement rules lengthen sales cycles, compelling vendors to maintain multi-jurisdiction regulatory teams.

1. Agfa HealthCare
2. Canon
3. FUJIFILM
4. Merative L.P.
5. Mckesson
6. Novarad
7. Koninklijke Philips
8. Sectra
9. Siemens Healthineers
10. Topcon
11. GE Healthcare
12. Carestream Health
13. Change Healthcare (Optum, Inc.)
14. Intelerad Medical Systems
15. RamSoft
16. Visage Imaging
17. Infinitt Healthcare
18. Konica Minolta Healthcare
19. Cerner Corporation (Orcale Health)
20. Hyland Healthcare
21. Mach7 Technologies

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing use of imaging devices
  • 4.2.2 Increasing burden of chronic diseases
  • 4.2.3 Enterprise-wide imaging adoption
  • 4.2.4 AI-ready architecture demand
  • 4.2.5 Reimbursement-linked image analytics
  • 4.2.6 Decentralized trials & tele-imaging
• 4.3 Market Restraints
  • 4.3.1 Data security & privacy concerns
  • 4.3.2 High capex & migration costs
  • 4.3.3 Vendor lock-in risk
  • 4.3.4 Cloud/AI skills gap
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Specialty
  • 5.1.1 Radiology PACS
  • 5.1.2 Cardiology PACS
  • 5.1.3 Pathology PACS
  • 5.1.4 Ophthalmology PACS
  • 5.1.5 Orthopedic PACS
  • 5.1.6 Oncology PACS
  • 5.1.7 Dermatology PACS
  • 5.1.8 Neurology PACS
  • 5.1.9 Women's Health PACS
  • 5.1.10 Other Specialty PACS
• 5.2 By Component
  • 5.2.1 Software
  • 5.2.2 Services
  • 5.2.3 Hardware
• 5.3 By Deployment Model
  • 5.3.1 On-premise PACS
  • 5.3.2 Web/Cloud-based Specialty PACS
  • 5.3.3 Hybrid PACS
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Diagnostic Imaging Centers
  • 5.4.3 Ambulatory Surgical Centers & Clinics
  • 5.4.4 Research & Academic Institutes
  • 5.4.5 Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Agfa HealthCare
  • 6.3.2 Canon Medical Systems
  • 6.3.3 Fujifilm Holdings Corporation
  • 6.3.4 Merative L.P.
  • 6.3.5 McKesson Corporation
  • 6.3.6 Novarad
  • 6.3.7 Philips Healthcare
  • 6.3.8 Sectra AB
  • 6.3.9 Siemens Healthineers
  • 6.3.10 Topcon Corporation
  • 6.3.11 GE Healthcare
  • 6.3.12 Carestream Health
  • 6.3.13 Change Healthcare (Optum, Inc.)
  • 6.3.14 Intelerad Medical Systems
  • 6.3.15 RamSoft
  • 6.3.16 Visage Imaging
  • 6.3.17 Infinitt Healthcare
  • 6.3.18 Konica Minolta Healthcare
  • 6.3.19 Cerner Corporation (Orcale Health)
  • 6.3.20 Hyland Healthcare
  • 6.3.21 Mach7 Technologies

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment